DEFA14A: Precipio, Inc. Adjourns Annual Meeting Due to Lack of Quorum, Rescheduled for June 21, 2024

Precipio, Inc.'s 2024 Annual Meeting of Shareholders was adjourned due to the absence of a quorum and will resume virtually on June 21, 2024.

Summary

• Precipio, Inc. adjourned its 2024 Annual Meeting of Shareholders on June 13, 2024, because a quorum was not present.
• The meeting will resume virtually on June 21, 2024, at 9 a.m. Eastern Time.
• The record date for determining shareholders eligible to vote remains April 19, 2024.
• Shareholders who have already submitted proxies do not need to vote again, unless they wish to change their vote.
• The company encourages shareholders as of the April 19, 2024 record date who have not yet voted to do so online at www.proxyvote.com or by telephone at 1-800-690-6903.
• Votes must be submitted by 11:59 p.m. Eastern Time on June 20, 2024.
• Shareholders can attend the virtual Annual Meeting by visiting www.virtualshareholdermeeting.com/PRPO2024.
• The company has filed a Definitive Proxy Statement with the SEC, available on the SEC's website and Precipio's website.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While the adjournment is a setback, the company is taking steps to address the issue and ensure shareholder participation.

Positives

• Shareholders who have already voted do not need to vote again unless they want to change their vote.
• The company provides multiple easy ways for shareholders to vote, including online, by phone, or through their broker.
• The company is making efforts to ensure shareholders are aware of the voting process and deadlines.

Negatives

• The Annual Meeting was adjourned due to a lack of quorum, indicating potential shareholder disengagement or difficulty in achieving participation.
• The adjournment necessitates additional effort and expense to reconvene the meeting.

Risks

• Failure to achieve a quorum at the reconvened meeting could lead to further delays and expenses.
• Low shareholder participation may reflect underlying concerns about the company's performance or governance.

Future Outlook

The company aims to complete the Annual Meeting on June 21, 2024, and encourages shareholder participation to achieve a quorum.

Management Comments

• Ilan Danieli, CEO, emphasized the importance of shareholders voting and provided instructions on how to do so.

Industry Context

This announcement is typical for publicly traded companies needing to ensure shareholder participation in corporate governance matters. Delays due to lack of quorum can be seen across various industries.

Comparison to Industry Standards

• Achieving quorum is a standard requirement for public companies like Precipio to conduct their annual meetings.
• Companies like Myriad Genetics (MYGN) and Exact Sciences (EXAS), also in the diagnostics space, face similar challenges in ensuring shareholder participation.
• The virtual meeting format is increasingly common, aligning with practices adopted by companies such as Teladoc Health (TDOC) to enhance accessibility.

Stakeholder Impact

• Shareholders are impacted by the delay and are encouraged to vote.
• The company faces additional expenses and administrative burden due to the adjournment.

Next Steps

• Shareholders are encouraged to vote before the reconvened Annual Meeting on June 21, 2024.
• The company will hold the virtual Annual Meeting on June 21, 2024.
• The company will record votes at the Annual Meeting in accordance with the most recently submitted proxy.

Key Dates

Keywords

Annual Meeting, Shareholders, Proxy Vote, Quorum, Precipio, PRPO, Diagnostics